Body Composition & Risk in Psoriatic Disease

Body Composition & Risk in Psoriatic Disease

From Inside GRAPPA by GRAPPA Network

April 8, 2026 · 18 min · Episode 24

About this episode

This episode discusses the impact of body composition on psoriatic disease and cardiometabolic risk with insights from Dr. Lyn Ferguson's research.

In this episode, host Dr. Mio Nakamura (University of Michigan) speaks with Dr. Lyn Ferguson (University of Glasgow) about her study on how body composition (not just weight) impacts psoriatic disease and cardiometabolic risk. This study was supported by a GRAPPA Pilot Research Grant. Highlights Obesity is strongly linked to worse psoriasis and psoriatic arthritis outcomes Visceral fat, liver fat, and muscle fat are more important than BMI alone Patients with psoriatic disease show: Higher visceral and ectopic fat Lower muscle volume Adverse muscle composition (low muscle + high fat) is a key risk marker: ~3× higher risk of type 2 diabetes 2× higher risk of heart disease May also help predict future psoriasis risk Connect Stay up to date with the latest in psoriatic disease research and GRAPPA initiatives: https://www.grappanetwork.org Hosted on Acast. See acast.com/privacy for more information.

People in this episode

Host: Dr. Mio Nakamura

Guest: Dr. Lyn Ferguson

Topics covered

  • body composition
  • psoriatic disease
  • cardiometabolic risk
  • obesity
  • muscle composition

Keywords

  • psoriatic disease
  • body composition
  • cardiometabolic risk
  • obesity
  • visceral fat
  • muscle volume
  • type 2 diabetes
  • heart disease

Mentioned in this episode

Organizations: University of Michigan, University of Glasgow, GRAPPA

More episodes of Inside GRAPPA

Explore listener stats, chart rankings, contacts and more on the Inside GRAPPA podcast page.